9C
REPL icon

9823 Capital’s Replimune Group REPL Stock Holding History

9823 Capital’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-18,332
Closed -$178K – 77
2025
Q4 		$178K Buy
+18,332
New +$156K 0.12% 54

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

9823 Capital's REPL Position: Q1 2026 in Review

9823 Capital sold out of Replimune Group (REPL) in Q1 2026, closing a stake of 18,332 shares — an estimated $178K sold.

9823 Capital first reported a position in REPL in Q4 2025 and held it in 1 quarter. The position peaked at $178K in Q4 2025. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • 9823 Capital reported no remaining Replimune Group position as of Q1 2026 after selling out during the quarter.
  • 9823 Capital sold 18,332 Replimune Group shares in Q1 2026, an estimated $178K.
  • 9823 Capital first reported a position in Replimune Group in Q4 2025 and held it in 1 quarter.
  • 9823 Capital's Replimune Group position peaked at $178K in Q4 2025.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on 9823 Capital's 13F filing for Q1 2026, filed 15 May 2026.